Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Culturelle is a leading consumer health brand specializing in probiotic supplements formulated to support digestive and immune health. The brand's products are centered around the scientifically studied probiotic strain Lactobacillus rhamnosus GG (LGG), which is recognized for its extensive clinical heritage. Originally marketed by i-Health, Inc., the brand is now a part of the DSM-firmenich portfolio following a series of acquisitions involving Amerifit Brands and Martek Biosciences. Culturelle offers a wide range of products tailored for infants, children, and adults, addressing indications such as occasional digestive upset and immune system maintenance. The brand maintains a dominant market position in the nutraceutical sector, emphasizing science-backed efficacy and high-quality manufacturing standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Culturelle.